Robert Morris
Overview
Explore the profile of Robert Morris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
3383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvero A, Wu S, Farrell A, Kim S, Wallbillich J, Winer I, et al.
Gynecol Oncol
. 2025 Feb;
194:71-79.
PMID: 39970633
Objective: The purpose of this study was to evaluate the transcriptomic profile of BRCA1 mutant (BRCA1mut) and BRCA2 mutant (BRCA2mut) HGSOC compared to homologous recombination wild-type (HRwt) tumors utilizing the...
2.
Kuhn F, Morris R
Graefes Arch Clin Exp Ophthalmol
. 2024 Dec;
263(1):1-2.
PMID: 39724476
No abstract available.
3.
Han W, Morris R, Bu K, Zhu T, Huang H, Cheng F
Can J Physiol Pharmacol
. 2024 Dec;
103(2):56-69.
PMID: 39620731
The FDA Adverse Event Reporting System (FAERS) is a large-scale repository of reports concerning adverse drug events (ADEs). The same published clinical study or report may be reviewed by multiple...
4.
Saed G, Fletcher N, Sharma H, Stenmark Tullberg A, Ittner E, Parris T, et al.
Mol Ther Oncol
. 2024 Sep;
32(3):200864.
PMID: 39290318
Lemur tail kinase 3 (LMTK3) belongs to a family of tyrosine kinases that are known to correlate with tumor grade and patient survival in some cancers. Here, we validated LMTK3...
5.
Jain D, Zaeim F, Wahidi M, Smith W, Alkaram W, Abu-Jamea A, et al.
Gynecol Oncol
. 2024 Sep;
190:272-282.
PMID: 39265465
Objective: To assess the influence of geographies and race on the survival outcomes in patients diagnosed with cervical squamous cell carcinoma (CSCC) across three continents. Methods: This multicontinental retrospective study...
6.
Fox A, Leonard G, Adzibolosu N, Wong T, Tedja R, Sharma S, et al.
Front Oncol
. 2024 Aug;
14:1432333.
PMID: 39104719
Introduction: Ovarian and other peritoneal cancers have a strong tendency to metastasize into the surrounding adipose tissue. This study describes an effect of the adipose microenvironment on upregulation of sialic...
7.
Vijay V, Karisani N, Shi L, Hung Y, Vu P, Kattel P, et al.
bioRxiv
. 2024 Jul;
PMID: 39026794
Biliary tract cancers (BTCs) are a group of deadly malignancies encompassing intrahepatic and extrahepatic cholangiocarcinoma, gallbladder carcinoma, and ampullary carcinoma. Here, we present the integrative analysis of 63 BTC cell...
8.
Fox A, Leonard G, Adzibolosu N, Wong T, Tedja R, Sharma S, et al.
bioRxiv
. 2024 May;
PMID: 38798490
Sialylation, the addition of negatively charged sialic acid sugars to terminal ends of glycans, is upregulated in most cancers. Hypersialylation supports multiple pro-tumor mechanisms such as enhanced migration and invasion,...
9.
Zhen Y, Liu K, Shi L, Shah S, Xu Q, Ellis H, et al.
Nat Commun
. 2024 May;
15(1):3805.
PMID: 38714664
Genomic alterations that activate Fibroblast Growth Factor Receptor 2 (FGFR2) are common in intrahepatic cholangiocarcinoma (ICC) and confer sensitivity to FGFR inhibition. However, the depth and duration of response is...
10.
Morris R, Ali R, Cheng F
Curr Drug Targets
. 2024 Apr;
25(7):454-464.
PMID: 38566381
Drug repurposing is an emerging approach to reassigning existing pre-approved therapies for new indications. The FDA Adverse Event Reporting System (FAERS) is a large database of over 28 million adverse...